We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

2 hedge funds and large institutions have $4.9M invested in Seelos Therapeutics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more call options, than puts

Call options by funds: $149K | Put options by funds: $47K

0% more funds holding

Funds holding: 2 → 2 (0)

30% less capital invested

Capital invested by funds: $7.03M → $4.9M (-$2.13M)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
$149K
Puts
$47K
Net Calls
+$102K
Net Calls Change
-$228K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GC
Guggenheim Capital
Illinois
-$35K
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$486
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.72M – – –
VAM
2
Visium Asset Management
New York
$1.66M – – –
California Public Employees Retirement System
3
California Public Employees Retirement System
California
$390K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$191K – – –
BFA
5
BlackRock Fund Advisors
California
$174K – – –
Northern Trust
6
Northern Trust
Illinois
$96K – – –
RCM
7
Rotella Capital Management
Washington
$80K – – –
Bank of New York Mellon
8
Bank of New York Mellon
New York
$76K – – –
CC
9
Callan Capital
California
$65K – – –
HighTower Advisors
10
HighTower Advisors
Illinois
$59K – – –
VKH
11
Virtu KCG Holdings
New York
$49K – – –
HCM
12
Highlander Capital Management
New Jersey
$43.8K – – –
RG
13
Rathbones Group
United Kingdom
$38K – – –
Hudson Bay Capital Management
14
Hudson Bay Capital Management
Connecticut
$35K – – –
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$35K – – –
SIM
16
Spark Investment Management
New York
$27K – – –
BA
17
BlackRock Advisors
Delaware
$25K – – –
Deutsche Bank
18
Deutsche Bank
Germany
$24K – – –
State Street
19
State Street
Massachusetts
$17K – – –
RC
20
Randolph Company
Ohio
$16K – – –
Citadel Advisors
21
Citadel Advisors
Florida
$15K – – –
FANJ
22
Financial Architects (New Jersey)
New Jersey
$12K – – –
TRCT
23
Tower Research Capital (TRC)
New York
$12K – – –
AIG
24
American International Group
New York
$9.26K – – –
BIM
25
BlackRock Investment Management
Delaware
$9K – – –
1
2

SEEL Hedge Fund Activity: Q3 2014 in Review

2 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q3 2014, worth a combined $4.9M — down 30% from $7.03M a quarter earlier.

Fund positioning in SEEL was balanced in Q3 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Guggenheim Capital, cutting an estimated $35K.

  • 2 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $4.9M of Seelos Therapeutics, Inc. Common Stock stock for Q3 2014, down 30% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q3 2014 and 0 closed out.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q3 2014 was Guggenheim Capital, an estimated $35K sold.

Based on aggregated 13F filings for Q3 2014.